ZNF407 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.839400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.177400E-01
Normal-vs-Stage2
8.241300E-04
Normal-vs-Stage3
1.377160E-01
Normal-vs-Stage4
2.007000E-01
Stage1-vs-Stage2
1.260420E-01
Stage1-vs-Stage3
6.109700E-02
Stage1-vs-Stage4
6.837800E-01
Stage2-vs-Stage3
1.503440E-01
Stage2-vs-Stage4
5.214600E-01
Stage3-vs-Stage4
1.345370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.503070E-03
Normal-vs-AfricanAmerican
1.160640E-01
Normal-vs-Asian
2.492300E-02
Caucasian-vs-AfricanAmerican
5.157600E-01
Caucasian-vs-Asian
1.344840E-01
AfricanAmerican-vs-Asian
2.425200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.259600E-03
Normal-vs-Female
3.240500E-03
Male-vs-Female
2.496400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.166400E-01
Normal-vs-Age(41-60Yrs)
8.995200E-03
Normal-vs-Age(61-80Yrs)
1.501570E-03
Normal-vs-Age(81-100Yrs)
9.380200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.805200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.656600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.171000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.100100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.536770E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.870200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.322900E-03
Normal-vs-Daily Drinker
1.243740E-02
Normal-vs-Weekly Drinker
4.295500E-03
Normal-vs-Occasional Drinker
2.207800E-02
Normal-vs-Social Drinker
4.567600E-02
Non Drinker-vs-Daily Drinker
9.802400E-01
Non Drinker-vs-Weekly Drinker
5.914600E-01
Non Drinker-vs-Occasional Drinker
2.468600E-01
Non Drinker-vs-Social Drinker
1.530950E-01
Daily Drinker-vs-Weekly Drinker
6.116600E-01
Daily Drinker-vs-Occasional Drinker
3.067600E-01
Daily Drinker-vs-Social Drinker
2.045400E-01
Weekly Drinker-vs-Occasional Drinker
1.114420E-01
Weekly Drinker-vs-Social Drinker
6.967900E-02
Occasional Drinker-vs-Social Drinker
7.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.466300E-02
Normal-vs-Grade 2
2.956000E-02
Normal-vs-Grade 3
1.401880E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.000400E-01
Grade 1-vs-Grade 3
4.722400E-01
Grade 1-vs-Grade 4
9.466300E-02
Grade 2-vs-Grade 3
3.427400E-01
Grade 2-vs-Grade 4
2.956000E-02
Grade 3-vs-Grade 4
1.401880E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.919970E-01
Normal-vs-NonDiabetic
2.719100E-03
Diabetic-vs-NonDiabetic
2.978000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.705970E-01
Normal-vs-NoPancreatitis
1.563840E-03
Pancreatitis-vs-NoPancreatitis
2.093200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.154470E-02
Normal-vs-N1
2.188400E-01
N0-vs-N1
9.072000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.157600E-01
Normal-vs-TP53-NonMutant
6.570300E-02
TP53-Mutant-vs-TP53-NonMutant
2.337500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
